SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 2.160+1.9%Nov 19 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (668)12/1/1998 2:44:00 PM
From: Dan Spillane  Read Replies (2) of 2539
 
The labeling issue is one for today and that's about it. Why?

Of course the spokespeople for competing cos. and interest groups will try to swing the labeling issue against Monsanto. This is expected given the fact that some of them are in the pay (directly or indirectly) of competing interests.

Since the drug was approved, I see the labeling thing as a minor issue. Why? If doctors know the drug is safer, they will prescribe it. This is a prescription drug, not an over-the-counter drug. So the consumer won't really be aware of the label at all. If this were sold directly to the consumer and not out of a pill bottle, I might take notice of this. But that isn't the case...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News